NGP asked Tosja K. Zywietz, Managing Director of Biosigna – Medical Diagnostics, how innovative technology will drive the future of the cardiac safety industry.
industry. Here, Eran Gabbai, CEO, CTO and inventor of Neowater describes how the technology could revolutionise research and development in the sector.
Outsourcing offers multiple benefits for pharmaceutical companies. NGP asked Marcel Velterop of Dr Reddy’s how it can help reduce costs, achieve higher levels of performance, free up resources for higher value activities and gain access to capabilities and resources that are not available internally.